Psilocybin in pharmacotherapy of obsessive-compulsive disorder
Pharmacological Reports August 1, 2024 Maja Owe-Larsson, Katarzyna Kamińska, Barbara Buchalska et al. 11 citations
Abstract Obsessive-compulsive disorder (OCD) is a chronic mental disease that affects approximately 2% of the population. Obsessions and compulsions are troublesome for patients and may disturb their everyday activities. The pathogenesis of this disease is still not fully elucidated, but dysfunctions of serotonin-, dopamine- and glutamate-mediated neurotransmission together with early...